News Channels

18 May 2017 Oncolytics Biotech® Announces ASCO Abstracts and Preliminary Data for Studies in Pancreatic and Prostate Cancers
18 May 2017 Aurinia Doses First Patient in AURORA Phase 3 Clinical Trial of Voclosporin in Lupus Nephritis
18 May 2017 FDA Approves KALYDECO(R) (ivacaftor) for More Than 900 People Ages 2 and Older with Cystic Fibrosis Who Have Certain Residual Function Mutations
17 May 2017 Rhythm Expands Phase 2 Clinical Trials of Setmelanotide to the Treatment of Bardet-Biedl Syndrome Obesity
17 May 2017 Concert Pharmaceuticals Announces Clinical Hold on CTP-543 Phase 2a Trial
17 May 2017 Aduro Biotech Announces Clinical Collaboration with Merck to Evaluate the Combination of Aduro’s CRS-207 with Merck’s KEYTRUDA® (Pembrolizumab) for the Treatment of Mesothelioma
17 May 2017 Longeveron Announces Publication of Phase 1 Safety and Efficacy Trial Results for Allogeneic Stem Cell Treatment in Frailty Patients
17 May 2017 Cinfa Biotech announces positive top-line data from second clinical study with pegfilgrastim biosimilar candidate B12019
17 May 2017 Bayer Receives FDA Priority Review For Investigational Anti-Cancer Compound Copanlisib
16 May 2017 Enterin's RASMET Study Enrolls First Patient With Parkinson's Disease
16 May 2017 ALPHAEON Submits Biologics License Application for DWP-450 Neuromodulator
16 May 2017 NLS Pharma Announces Phase 2 Study Of NLS-1 (Mazindol) In Adult ADHD Patients Has Met All Primary And Secondary Endpoints
16 May 2017 Synlogic and Mirna Therapeutics Agree to Merger
16 May 2017 X-Chem and Vertex Enter into Multi-Target Genetic Disease Collaboration
16 May 2017 Beactica Announces Glioblastoma Research Collaboration with Uppsala University and the DDD Platform at SciLifeLab
16 May 2017 Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting MAGE-A4 in Multiple Solid Tumors
15 May 2017 Selecta Biosciences Announces New Preclinical Gene Therapy Data at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
15 May 2017 ToolGen, Inc. Announces Poster Presentation on Genome Editing of Human T Cells at 2017 American Society for Gene and Cell Therapy (ASGCT) Annual Meeting
15 May 2017 Tactiva Therapeutics Presents Positive Data on Novel Dual CD4/CD8 T Cell Receptor in Preclinical Models of Cancer
15 May 2017 Eiger BioPharmaceuticals Completes Enrollment of Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top